Innate Pharma IPHA Growth Metrics (2020-2026)

NASDAQ IPHA
$1.60 -0.10 (-5.88%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Innate Pharma Quarterly Growth Metrics

Periods 12 quarters
Latest Jun 2026

Innate Pharma growth metrics data for the quarter ended Jun 2026. These growth metrics cover 12 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025 Jun2026
Growth Ratios
EBIT Margin Growth (1y) -8.54M-40.04M8.36M
EBIT Margin Growth (3y) -8.44M-40.22M
EBIT Margin Growth (5y) -40.12M
EBT Margin Growth (1y) -6.87M-38.09M7.15M
EBT Margin Growth (3y) -6.87M-37.82M
EBT Margin Growth (5y) -37.82M
FCF Margin Growth (1y) -29.28M23.37M-34.56M
FCF Margin Growth (3y) -28.53M-40.47M
FCF Margin Growth (5y) -39.72M
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) 78.29%-657.82%-965.87%0.59%56.91%-2,994.25%-162.33%28.84%-24.66%-50.23%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y) -32.00%39.75%-65.90%3.70%-3.96%-12.11%-221.00%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y) -21.06%-36.94%-71.72%0.93%
Net Margin Growth (1y) -6.87M-38.09M7.15M
Net Margin Growth (3y) -5.94M-37.82M
Net Margin Growth (5y) -36.88M
Return on Assets [ROA] Growth (1y)ROA Growth (1y) -0.00M-0.00M446.000.00M99.00-0.00M-0.00M-0.01M-0.02M
Return on Assets [ROA] Growth (3y)ROA Growth (3y) -0.00M-918.00-0.00M-0.01M-0.02M
Return on Assets [ROA] Growth (5y)ROA Growth (5y) -0.02M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) -0.00M880.00718.00-0.00M-0.01M-0.03M-0.08M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y) -0.01M-0.01M-0.03M-0.08M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y) -0.09M
Return on Equity [ROE] Growth (1y)ROE Growth (1y) -0.01M-0.00M-0.01M0.01M-0.00M-0.03M-0.13M
Return on Equity [ROE] Growth (3y)ROE Growth (3y) -0.01M-0.03M-0.13M
Return on Sales [ROS] Growth (1y)ROS Growth (1y) -8.54M-40.04M8.36M
Return on Sales [ROS] Growth (3y)ROS Growth (3y) -8.44M-40.22M
Return on Sales [ROS] Growth (5y)ROS Growth (5y) -40.12M

Innate Pharma Growth Metrics API

Pull Innate Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IPHA&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY